Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Dec 3, 2021

Accession no.
0001209191-21-067888
Filed
Dec 3, 2021
Trade date
Nov 1-30, 2021
Filing delay
32 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.09K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockPPurchaseAcquired+15$2.67+$40.055,769,789Direct
Nov 2, 2021Common StockPPurchaseAcquired+15$2.63+$39.455,769,804Direct
Nov 3, 2021Common StockPPurchaseAcquired+15$2.71+$40.655,769,819Direct
Nov 4, 2021Common StockPPurchaseAcquired+15$2.73+$40.955,769,834Direct
Nov 5, 2021Common StockPPurchaseAcquired+15$2.71+$40.655,769,849Direct
Nov 8, 2021Common StockPPurchaseAcquired+15$2.95+$44.255,769,864Direct
Nov 9, 2021Common StockPPurchaseAcquired+15$3.21+$48.155,769,879Direct
Nov 10, 2021Common StockPPurchaseAcquired+15$2.94+$44.15,769,894Direct
Nov 11, 2021Common StockPPurchaseAcquired+15$2.83+$42.455,769,909Direct
Nov 12, 2021Common StockPPurchaseAcquired+15$2.67+$40.055,769,924Direct
Nov 15, 2021Common StockPPurchaseAcquired+15$2.71+$40.655,769,939Direct
Nov 16, 2021Common StockPPurchaseAcquired+15$2.66+$39.95,769,954Direct
Nov 17, 2021Common StockPPurchaseAcquired+15$2.58+$38.75,769,969Direct
Nov 18, 2021Common StockPPurchaseAcquired+15$2.58+$38.75,769,984Direct
Nov 19, 2021Common StockPPurchaseAcquired+15$2.55+$38.255,769,999Direct
Nov 22, 2021Common StockPPurchaseAcquired+15$2.35+$35.255,770,014Direct
Nov 23, 2021Common StockPPurchaseAcquired+15$2.29+$34.355,770,029Direct
Nov 24, 2021Common StockPPurchaseAcquired+35$2.31+$80.855,770,064Direct
Nov 26, 2021Common StockPPurchaseAcquired+35$2.26+$79.15,770,099Direct
Nov 29, 2021Common StockPPurchaseAcquired+35$2.23+$78.055,770,134Direct
Nov 30, 2021Common StockPPurchaseAcquired+35$4.61+$161.355,770,169Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)